Agenus Inc

Insider Reports History

Entity
Company
Location
3 Forbes Road, Lexington, MA
Signature
/s/Christine Klaskin, Vice President, Finance
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Agenus Inc:

Stock Role Class Num Shares Value Price $ Report Date Ownership
MiNK Therapeutics, Inc. 10%+ Owner Common Stock 21.8M $22.6M $1.04 Oct 16, 2023 Direct

Insider Reports Filed by Agenus Inc

Symbol Company Period Transactions Value $ Form Type Date Filed Role
INKT MiNK Therapeutics, Inc. Oct 12, 2023 3 $25.3K 4 Oct 16, 2023 10%+ Owner
INKT MiNK Therapeutics, Inc. Oct 4, 2023 1 $16.4K 4 Oct 6, 2023 10%+ Owner
INKT MiNK Therapeutics, Inc. Aug 29, 2023 1 $45K 4 Aug 31, 2023 10%+ Owner
INKT MiNK Therapeutics, Inc. Aug 24, 2023 2 $281K 4 Aug 28, 2023 10%+ Owner
INKT MiNK Therapeutics, Inc. May 10, 2023 2 $66.6K 4 May 12, 2023 10%+ Owner
INKT MiNK Therapeutics, Inc. May 5, 2023 0 $0 4/A May 26, 2023 10%+ Owner
INKT MiNK Therapeutics, Inc. May 3, 2023 4 $260K 4 May 5, 2023 10%+ Owner
INKT MiNK Therapeutics, Inc. May 1, 2023 1 $0 4/A May 26, 2023 10%+ Owner
INKT MiNK Therapeutics, Inc. Oct 19, 2021 3 $16.8M 4 Oct 20, 2021 10%+ Owner
INKT MiNK Therapeutics, Inc. Oct 13, 2021 0 $0 3 Oct 20, 2021 10%+ Owner